San Diego, CA (PRWEB) June 03, 2013
Resource4thePeople today updates consumers on the status of numerous lawsuits alleging links between Tylenol products and liver cancer with the news that a steering committee has been appointed for the plaintiffs in consolidated federal Tylenol cases.*
U.S. District Court Judge Lawrence Stengel of the Eastern District of Pennsylvania made the appointments in a multidistrict litigation that has been created for Tylenol cases involving common allegations involving allegations of liver failure problems from the use of Tylenol.
"This is an important development for consumers who may have suffered alleged liver failure problems from the use of Tylenol and other acetaminophen painkillers because the judge has set up a process in which certain attorneys will play leading roles in the progress of the litigation," said Resource4thePeople.
“This will enable pre-trial evidence gathering and other legal requirements to progress in an orderly process under the oversight of Judge Stengel. This step streamlines the process by which the evidence in these important cases is gathered and organized.”
As this litigation moves forward, Resource4thePeople is informing consumers that even though these cases have been consolidated there is no court order from the judge preventing new cases from being filed.
"We want to assure consumers that our national network of attorneys will continue to provide no-cost consultations for consumers seeking information about the legal options they may have in seeking compensation for alleged Tylenol liver failure problems."
Most of the lawsuits alleging links between Tylenol and severe liver damage were filed after a June 24, 2009 safety communication** (updated on April 11, 2013) was issued by the Food and Drug Administration warning that the painkiller Tylenol (acetaminophen) when taken in doses stronger than the recommended amount can cause life-threatening health problems.
The FDA said it issued the warning after an advisory committee of medical experts and physicians met to address the problem of liver injury related to the use of acetaminophen in both over-the-counter (OTC) and prescription products.
The FDA said acetaminophen is the generic name of a drug found in many common brand name OTC products such as Tylenol, as well as prescription products such as Vicodin and Percocet.
“Acetaminophen is an important drug, and its effectiveness in relieving pain and fever is widely known,” said the FDA. “This drug is generally considered safe when used according to the directions on its labeling. But taking more than the recommended amount can cause liver damage, ranging from abnormalities in liver function blood tests, to acute liver failure, and even death.”
Resource4thePeople will continue to update consumers about the progress of this litigation as new developments are posted. As of today no trial dates have been set in the litigation.
The consolidated cases were assigned to Judge Stengel over the objections of the manufacturers of Tylenol and other acetaminophen-based products, according to an April 5, 2013 Reuters News Service report:***
"A group of drugmakers have lost their bid to prevent the consolidation in federal court of over two dozen personal injury cases involving the painkiller acetaminophen, the latest such defeat for pharmaceuticals seeking to bar the formation of a multidistrict litigation.
"Drugmakers McNeil/Johnson & Johnson, Novartis and L. Perrigo Co had argued that 27 lawsuits claiming that ingesting acetaminophen can cause liver injury lacked sufficient commonality to merit MDL status."
Resource4thePeople has discovered that many of the consumers who have made inquiries over this litigation were unaware of the possible side effects from Tylenol products that allegedly could cause liver damage or failure. These are now being detailed on the Tylenol official web site.****
Also included on the web site is this warning:
“It is important to be aware of the ingredients in all medications that you may be taking. Acetaminophen (APAP) is a common component of many different over-the-counter and prescription medications. You should not take two or more products that contain acetaminophen at the same time. Taking more than the recommended dose (overdose) of acetaminophen may cause liver damage.”
“These are serious health issues that -- because of the huge popularity of these drugs -- are causing widespread concern among consumers,” said Resource4thePeople “Our attorneys are now actively investigating the claims that are being alleged in increasing numbers by consumers concerned about side effects.”
“The creation of a multidistrict litigation is an important milestone in the progress of a growing number of lawsuits claiming that the use of Tylenol and other acetaminophen-based pain-killers can put patients at significantly increased risk of suffering life-threatening liver damage,” said Resource4thePeople.
“Resouce4thePeople remains committed to providing updates about the progress of this litigation and is also providing complimentary legal consultations to individuals who may have suffered liver damage from Tylenol use. We welcome their inquiries and will investigate the merits of such cases.”
In seeking consolidation into a multidistrict litigation, attorneys for the plaintiffs requested that the 28 cases currently pending against McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson be coordinated and consolidated at the federal courthouse in Philadelphia.
“All of the products liability cases referenced by the plaintiffs’ lawyers allege that McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” according to the filings for their petition.*****
Resource4thePeople said that the consultations with Tylenol liver damage allegation attorneys can provide legal options to men, women and children who allegedly have suffered liver damage or failure due to their use of Tylenol and other products containing the ingredient acetaminophen.
*In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation; Case